Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Sun Pharma
Sun Pharma
BSE: 524715NSE: SUNPHARMAISIN: INE044A01036

21st-Oct-2019 15:22Source: BSE

Sun Pharmaceutical Industries - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Ashok Bhuta
Designation :- Authorised Signatory

Sections
Follow us on
Available On